Jacqueline Brown, MD

• Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy

  • Phase

    I
  • Conditions

    Metastatic Urothelial Carcinoma, Unresectable Urothelial Carcinoma
  • Location

    Winship Cancer Institute

• Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment, MODERN Study

  • Phase

    II/III
  • Conditions

    Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors

  • Phase

    I
  • Conditions

    Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm, Triple Negative Breast Cancer, Non-small Cell Lung Cancer, Esophageal Cancer, Pancreatic Cancer, Ovarian Cancer, Cervical Cancer, Head and Neck Squamous Cell Carcinoma, Prostate Cancer, Renal Pelvis Cancer, Bladder Cancer
  • Location

    Winship Cancer Institute

• A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

  • Phase

    I
  • Conditions

    Metastatic Solid Tumor
  • Location

    Winship Cancer Institute

• A Study of DB-1310 in Advanced/Metastatic Solid Tumors

  • Phase

    I/II
  • Conditions

    Advanced Solid Tumor
  • Location

    Winship Cancer Institute

• A Study of ACR-368 in Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma

  • Phase

    I/II
  • Conditions

    Platinum-resistant Ovarian Cancer, Endometrial Adenocarcinoma, Urothelial Carcinoma
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

• Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

  • Phase

    II
  • Conditions

    Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Neoplasm, Malignant Ureter Neoplasm, Malignant Urethral Neoplasm, Metastatic Bladder Carcinoma, Stage III Bladder Cancer AJCC v8, Stage IV Bladder Cancer AJCC v8, Unresectable Bladder Carcinoma, Urachal Adenocarcinoma, Bladder Adenocarcinoma
  • Location

    Emory University Hospital Midtown, Emory Saint Joseph's Hospital, Winship Cancer Institute

• Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

  • Phase

    II/III
  • Conditions

    Renal Pelvis and Ureter Urothelial Carcinoma
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

• A Beta-only IL-2 ImmunoTherapY Study

  • Phase

    I/II
  • Conditions

    Advanced Solid Tumor, Unresectable Solid Tumor, Clear Cell Renal Cell Carcinoma, Triple Negative Breast Cancer, Non-Small Cell Lung Cancer Squamous, Non-Small Cell Lung Cancer Non-squamous, Colorectal Cancer (MSI-H), Gastric Cancer, Cervical Cancer, Basal Cell Carcinoma, Bladder Cancer, Merkel Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck, Cutaneous Squamous Cell Carcinoma, Pleural Mesothelioma, Esophageal Cancer, Endometrial Carcinoma, Solid Tumor, Solid Tumor, Adult, MSI-H Solid Malignant Tumor, Cancer With A High Tumor Mutational Burden, Epithelial Ovarian Carcinoma, Primary Peritoneal Cancer, Gastroesophageal Junction (GEJ) Cancer, Acral Melanoma, Mucosal Melanoma, Cutaneous Melanoma, DMMR Solid Malignant Tumor, Fallopian Tube Cancer, Ovarian Cancer, MSI-H Cancer, DMMR Cancer, Pancreas Adenocarcinoma (MSI-H), Skin Cancer, Viral Cancer, Cervical Cancers, Endometrial Cancer
  • Location

    Emory University Hospital Midtown, Winship Cancer Institute

Cabozantinib plus Pembrolizumab as First-line Therapy for Cisplatin-ineligible Advanced Urothelial Carcinoma: The PemCab Trial.

European urology oncology

Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.

American journal of clinical pathology

Advancing Principled Pharmacoepidemiologic Research to Support Regulatory and Healthcare Decision Making: The Era of Real-World Evidence.

Clinical pharmacology and therapeutics

Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial.

Nature cancer

Real-World Outcomes in Patients with Advanced Penile Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Single Institution Experience.

Journal of immunotherapy and precision oncology

Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors.

Therapeutic advances in medical oncology

PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation.

Cancer

Neoadjuvant cabozantinib restores CD8+ T cells in patients with locally advanced non-metastatic clear cell renal cell carcinoma: a phase 2 trial.

Research square

Adjuvant Therapy for Non-Clear Cell Renal Cell Carcinoma-The Ascent Continues.

JAMA network open

Billing for Electronic Patient-Physician Communications: An Ethical Analysis.

JCO oncology practice

The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.

Cancer

Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy.

Clinical genitourinary cancer

The Evolving Landscape of Biomarkers for Immune Checkpoint Blockade in Genitourinary Cancers.

Biomarker insights

Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.

Cancer

Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors.

The oncologist

The Genomic Landscape of Urothelial Carcinoma with High and Low ERBB2 Expression.

Cancers

Concordance of Ethyl Glucuronide, Blood Alcohol Content, and Self-Reported Alcohol Use in Russian Women with HIV and Hepatitis C Virus Co-Infection.

AIDS and behavior

Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Baseline Neutrophil-to-Eosinophil Ratio Is Associated with Outcomes in Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors.

The oncologist

Challenges and opportunities in the management of non-urothelial bladder cancers.

Cancer treatment and research communications

Combination Immune Checkpoint Blockade Regimens for Previously Untreated Metastatic Renal Cell Carcinoma: The Winship Cancer Institute of Emory University Experience.

Journal of immunotherapy and precision oncology

Metastatic Clear-Cell Renal Cell Carcinoma in the Era of Immune Checkpoint Inhibitors: Therapies and Ongoing Trials.

Cancers

Blood-Based Next-Generation Sequencing in Adrenocortical Carcinoma.

The oncologist

Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer.

Urologic oncology

Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients.

Clinical genitourinary cancer

Advances in Knowledge and Management of Immune-Related Adverse Events in Cancer Immunotherapy.

Frontiers in endocrinology

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah's witness: A case report.

Frontiers in oncology

05/12/2025

We were very impressed with Dr. Brown and very thankful that she was assigned my case. Dr. Brown was very caring and took a lot of time explaining my diagnoses and treatments options. We feel so much better and our consult with Dr. Brown

05/06/2025

Dr Brown is a great listener and very knowledgeable about her recommendations and treatments.

05/03/2025

Dr. Brown is the most considerate, patient and compassionate Dr. I've ever experienced. She took the time to carefully explain all options and asked if I had questions to make sure I understood. She took the time to take me downstairs to "ring the bell", indicating the end of my 2 year prostate hormonal treatment. She asked if she could be in one of the pictures. She is the ultimate professional with a compassionate heart.

04/29/2025

Dr Brown was excellent

04/24/2025

Dr. Brown is the easiest doctor I have ever conversed with. I believe she is capable of reading minds. Very thoughtful and thorough with our discussions.

04/22/2025

Very good attention to details. I felt that she was there and focused on my and my situation. She was not in a hurry or passing thing off. It was a very good visit.

04/15/2025

The team are excellent

04/15/2025

Dr. Brown has excellent medical skills and is caring towards her patients.

04/01/2025

Dr. Brown is exceptional in her approach and care.

03/20/2025

Dr. Brown is both caring and considerate and she clearly knows what she is doing.

03/07/2025

Dr. Brown explained the care in detail, and was friendly, professional and empathetic to our concerns and needs.

02/27/2025

I will always recommend Dr Brown to anyone who is looking for a kind, loving and caring doctor.

02/26/2025

Good

02/25/2025

Very professional and caring.

02/25/2025

Inreqlly like Dr Brown! She has a great smile! She listened, and paid attention to me. Five Stars!

02/20/2025

Both Dr Brown and Dr Woods are excellent listeners and were very familiar with my medical history.

02/13/2025

Have already recommended her and Emory to friends

02/06/2025

Jacquiline was absolutely fantastic. She made us feel special and so supportive.

01/29/2025

Dr Brown as always was sensitive to my situation and set out an appropriate, detailed treatment plan

01/19/2025

Dr. Brown is the best doctor we have seen so far during this cancer journey. She was very informative, knowledgeable and explained the different options and why certain options are not recommended and the best option to consider and how to approach it and what to expect. We liked her very much.

01/17/2025

Dr.brown was very informative. She showed genuine concern for my personal situation , she also showed no concern toward how much time she spent explaining my concerns and questions. A rare thing in today's doctors . I would highly recommend her to anyone.

01/16/2025

Dr. Brown is amazing and makes me feel at ease

01/15/2025

Dr. Brown, is excellent in explaining complex medical protocols in language layman can comprehend.

01/14/2025

Dr Brown is a phenomenal doctor. She addressed my current and future concerns beautifully.

01/13/2025

Dr. Brown is very approachable and always takes time to answer all my questions.

01/09/2025

Dr. Brown isn't only a skilled doctor, but also very responsible to her patients. The dosage of cancer treatment drug given to me by other doctor caused serious side effects , so I even wanted to give up treatment . After Dr. Brown took over my treatment, she adjusted the dosage and found a balance between medication and quality of life for me. I feel very good.

12/27/2024

From the beginning of my post-surgery phase, Dr Brown has provided excellent care and expert guidance as we navigate my unique medical condition. She is frank but compassionate and her insight is instrumental to providing the best balance of medical care and daily living one could expect.

12/19/2024

Wonderful team

12/11/2024

The expertise of the Doctor was exceptional! Valuable insight was gained and future plans were discussed

12/05/2024

Great!

12/03/2024

Good

11/26/2024

5 stars all around for Dr Brown

11/26/2024

Couldn't be happier

11/12/2024

Dr. Brown is very patient with my dad who can be a bit stubborn and not the easiest person

11/07/2024

Very thoughtful

10/26/2024

Best visit I ever had with a Dr. Took her time and explained all options and treatments. I felt that she listened to me and left feeling that I would receive excellent treatment with her.

10/18/2024

Really appreciate how Dr. Brown explains everything

10/16/2024

I would recommend the time with Dr Brown

07/18/2024

Dr. Brown is always very concerned. She takes time to explain the situation and the logic behind her recommendations. She listens to my questions and concerns and opens the discussion for my input. She is an excellent doctor.

07/08/2024

Care provider was awesome

07/04/2024

Outstanding doctor.

06/26/2024

Doctor Brown is great. She spent a lot of time learning about me.

06/25/2024

Good

06/21/2024

Dr. Brown was so kind and thorough. She listened to all of Dad's concerns as well as the concerns of family members. She explained Dad's situation, his options, risks and rewards with great clarity and patience. Thank you Dr. Brown so very much!

06/20/2024

Dr. Brown's, with exceptional thoroughness, helped me to understand the different paths available once the result of the upcoming Pet CT PSMA is available. I am most appreciative.

06/12/2024

Excellent

06/12/2024

Good

06/12/2024

Good experience